Oncology & Cancer

Researchers develop optimised PSA screening program

As an indicator of prostate cancer, the PSA test is regarded in urology as highly controversial since it is not always unequivocal. A team of researchers from the Comprehensive Cancer Center at the MedUni Vienna and Vienna ...

Oncology & Cancer

Swedish model for PSA testing has little effect on mortality

The spontaneous PSA testing that has been applied in Sweden in recent decades has only had a marginal effect on mortality. An organized screening focused on those who have the most to gain would, however, reduce the risk ...

Oncology & Cancer

Article offers guidance on discussing PSA with patients

(HealthDay)—Discussion of prostate-specific antigen (PSA) screening should focus on current guidelines and emphasize shared decision making, according to an article published Feb. 11 in the Urology Times.

page 6 from 13